Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News

10:42 EDT 20th September 2018 | BioPortfolio

Showing News Articles 1–25 of 420,000+

Thursday 20th September 2018

GS $FGEN data are an incremental positive for Roxa (and follows positive Ph3 data in China last year,but remain focused on cardiovascular profile of drug (MACE),remaining Ph3 trials between now&YE18, with pooled MACE data expected in early 2019, significa

GS $FGEN data are an incremental positive for Roxa (and follows positive Ph3 data in China last year,but remain focused on cardiovascular profile of drug (MACE),remaining Ph3 trials between now&YE18, with pooled MACE data expected in early 2019, significant catalyst for shares. https://twitter.com/tgtxdough/status/1042767836765138945 …

GS $FGEN FibroGen Inc. (FGEN): First Roxa Ph3 EU data a positive; main focus on pooled MACE data in early 1Q

GS $FGEN FibroGen Inc. (FGEN): First Roxa Ph3 EU data a positive; main focus on pooled MACE data in early 1Q

OncLive® Seeks Nominations for 7th Annual Giants of Cancer Care® Awards Program

This distinguished award recognizes those who have made an impact in the lives of patients with cancer OncLive®, the leading digital provider of resources and information to oncology professionals, is now accepting nominations for the 2019 Giants of Cancer Care® recognition program, which honors medical and scientific experts from the field of oncolo...

$ARGX Wedbush We are adding ARGX based on increasing confidence in efgartigimod’s broad market opportunity in antibody-mediated autoimmune diseases.

$ARGX Wedbush We are adding ARGX based on increasing confidence in efgartigimod’s broad market opportunity in antibody-mediated autoimmune diseases.

Talks between Boots and PDA Union end without agreement

Talks between Boots and the Pharmacists’ Defence Association Union over the future representation of Boots pharmacists have ended without agreement.

Novo Nordisk - Oral semaglutide demonstrates greater reductions in HbA1c and body weight and comparable number of adverse events vs dulaglutide in Japanese people with type 2 diabetes

Bagsværd, Denmark, 20 September 2018 - Novo Nordisk today announced the headline results from PIONEER 10, a phase 3a trial with oral semaglutide vs once-weekly subcutaneous dulaglutide, both in combination with one oral antidiabetic drug in Japanese adults with type 2 diabetes. Oral semaglutide is an investigational GLP-1 analogue taken once daily as a tablet. The trial investigat...

Acarix CADScor®System for early rule-out of Coronary Artery Disease (CAD) gains traction from established German users.

Press release Malmö, September 20, 2018 Acarix CADScor®System for early rule-out of Coronary Artery Disease (CAD) gains traction from established German users. Acarix AB (publ) ("Acarix"), today reported positive feedback from German users of its handheld CADScor®System for ruling out CAD.  Germany is an important market and Acarix offers a reimbursement code for private pati...

Grifols secures FTC’s conditional approval for Biotest US acquisition

Grifols is a global healthcare company based in Spain. Biotest US is a healthcare company based in Florida. According to the complaint, which was announced in August 2018, The post Grifols secures FTC’s conditional approval for Biotest US acquisition appeared first on Pharma Business review.

$COOL insider purchase https://www.sec.gov/Archives/edgar/data/1076682/000149315218013438/0001493152-18-013438-index.htm …

$COOL insider purchase https://www.sec.gov/Archives/edgar/data/1076682/000149315218013438/0001493152-18-013438-index.htm …

Next Gen Accountable Care Organizations Form Coalition to Advance Performance-Based Risk

Next Gen ACO Coalition will strengthen and accelerate the move to value-based arrangements Twenty-nine Next Generation Accountable Care Organizations (ACOs) have formed a new coalition to advocate for the preservation and expansion of the Next Generation ACO program — a program which has benefited individuals, communities and federal payers since its...

OPPY $SRNE updated market model to reflect ZTlido’s recently announced pricing and availability data. We now assume US launch in October (previously 3Q) followed by an EU launch in 3Q19 (previously 1Q19). As a result, the contribution from ZTlido in our

OPPY $SRNE updated market model to reflect ZTlido’s recently announced pricing and availability data. We now assume US launch in October (previously 3Q) followed by an EU launch in 3Q19 (previously 1Q19). As a result, the contribution from ZTlido in our valuation of Sorrento 10PT

Zika Vaccine Shows Promise Against Deadly Brain Cancer

NewsResearchers have developed a live-attenuated Zika vaccine to target and kill glioblastoma stem cells hiding out in brain tissue.

D1 Training Flexes Franchise Expansion Plans in Texas

National Athletic-Based Training Fitness Center Plans to Add 25 New Locations by 2023 D1 Training, a leading fitness concept utilizing the five basic tenets of athletic-based training to help people of all ages achieve their sport and fitness goals, has announced that it will be targeting the state of Texas for growth. The brand anticipates open...

Survey Finds Today’s Children Are Spending 35% Less Time Playing Freely Outside

Commissioned Survey from Kamik Uncovers Alarming Generational Decline in Outdoor Free Play Experiences;Company Launches #FreeYourPlay Movement to Encourage Families to Step Outside and Bring Freedom Back to Children’s Play Kamik, a leading footwear and apparel manufacturer, today announced new survey result findings that indicate a significant...

Nuvera Marks 8 Years of Enhancing Patient Experience for Specialty Therapeutics

Nuvera Life Science Consulting, a leading advisor on patient-centered experiences for specialty therapeutics, is celebrating eight years of partnering with top U.S. and international pharmaceutical and biotech companies to deliver award-winning patient support programs across 24 therapeutic areas. Founded in 2010, Nuvera understa

ZHealth Launches New Cardiovascular Software That Improves Both Documentation and Coding Accuracy

This week, ZHealth unveiled Etch™, the first-ever software platform that successfully addresses both the documentation and the coding challenges of complex cardiovascular procedures. Etch™ will be launched at the 2018 American Health Information Management Association (AHIMA) convention in Miami Beach, Florida. This press release features multimedia. Vi...

We've published our 2017/2018 Corporate Responsibility Report. Read about our commitment to creating sustainable value for our business and society: https://bit.ly/2NnE6rY  $MRKpic.twitter.com/jDyXMggJ9S

We've published our 2017/2018 Corporate Responsibility Report. Read about our commitment to creating sustainable value for our business and society: https://bit.ly/2NnE6rY  $MRK pic.twitter.com/jDyXMggJ9S

Discovery Could Explain Failed Clinical Trials for Alzheimer's

NewsResearchers have discovered a vicious feedback loop underlying brain degeneration in Alzheimer's disease which may explain why so many drug trials have failed.

On the Nature cover this week: Grow with the flow. Tissues ‘melt’ like glass to shape vertebrate embryos https://go.nature.com/2QLG4Av pic.twitter.com/9l11VhlTl0

On the Nature cover this week: Grow with the flow. Tissues ‘melt’ like glass to shape vertebrate embryos https://go.nature.com/2QLG4Av  pic.twitter.com/9l11VhlTl0

FDA schedules Nov 1 advisory committee to review Alkermes' buprenorphine and samidorphan, which is proposed for adjunctive treatment of major depressive disorder $ALKS https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-20571.pdf …pi

FDA schedules Nov 1 advisory committee to review Alkermes' buprenorphine and samidorphan, which is proposed for adjunctive treatment of major depressive disorder $ALKS https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-20571.pdf … pic.twitter.com/38ECRvXuW4

FDA encourages appropriate prescribing of opioids

The FDA has updated its Opioid Analgesic REMS to ensure caregivers and patients use opioids effectively... The post FDA encourages appropriate prescribing of opioids appeared first on European Pharmaceutical Review.

Chemical Tag Makes the Difference in Cell Fate, Gene Expression

NewsScientists have uncovered the role of special chemical tags in controlling vital genes involved in early mammalian development.

Darwin’s Survival of the Fittest is Immune to Climate Change

NewsFinally some good climate change news: the insects and plants currently on Earth have a better chance against the changing climate than previously thought. Staff Author:&nbs

HMP’s Journal of Clinical Pathways and Community Oncology Alliance Announce Partnership

Collaboration will advance the organizations’ shared mission to improve oncology care delivery MALVERN, Pa. (PRWEB) September 20, 2018 HMP, a leader in health care events and education, today announced that its peer-reviewed publication, Journal of Clinical Pathways®, has formed a strategic partnership with Community Oncology Alliance® (COA), a nonprofit organization dedicated to advo...

$TOCA PT raised to $22 from $15 at FBR

$TOCA PT raised to $22 from $15 at FBR


Advertisement
Quick Search
Advertisement
Advertisement

 

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.